Anti-DHCR7 monoclonal antibody

Pre-made anti-DHCR7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DHCR7/DHCR7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0689-Ab-1/ GM-Tg-hg-IP0689-Ab-2Anti-Human DHCR7 monoclonal antibodyHuman
GM-Tg-rg-IP0689-Ab-1/ GM-Tg-rg-IP0689-Ab-2Anti-Rat DHCR7 monoclonal antibodyRat
GM-Tg-mg-IP0689-Ab-1/ GM-Tg-mg-IP0689-Ab-2Anti-Mouse DHCR7 monoclonal antibodyMouse
GM-Tg-cynog-IP0689-Ab-1/ GM-Tg-cynog-IP0689-Ab-2Anti-Cynomolgus/ Rhesus macaque DHCR7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0689-Ab-1/ GM-Tg-felg-IP0689-Ab-2Anti-Feline DHCR7 monoclonal antibodyFeline
GM-Tg-cang-IP0689-Ab-1/ GM-Tg-cang-IP0689-Ab-2Anti-Canine DHCR7 monoclonal antibodyCanine
GM-Tg-bovg-IP0689-Ab-1/ GM-Tg-bovg-IP0689-Ab-2Anti-Bovine DHCR7 monoclonal antibodyBovine
GM-Tg-equg-IP0689-Ab-1/ GM-Tg-equg-IP0689-Ab-2Anti-Equine DHCR7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0689-Ab-1/ GM-Tg-hg-IP0689-Ab-2; GM-Tg-rg-IP0689-Ab-1/ GM-Tg-rg-IP0689-Ab-2;
GM-Tg-mg-IP0689-Ab-1/ GM-Tg-mg-IP0689-Ab-2; GM-Tg-cynog-IP0689-Ab-1/ GM-Tg-cynog-IP0689-Ab-2;
GM-Tg-felg-IP0689-Ab-1/ GM-Tg-felg-IP0689-Ab-2; GM-Tg-cang-IP0689-Ab-1/ GM-Tg-cang-IP0689-Ab-2;
GM-Tg-bovg-IP0689-Ab-1/ GM-Tg-bovg-IP0689-Ab-2; GM-Tg-equg-IP0689-Ab-1/ GM-Tg-equg-IP0689-Ab-2
Products NameAnti-DHCR7 monoclonal antibody
Formatmab
Target NameDHCR7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DHCR7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0689-Ag-1Recombinant multi-species DHCR7/ SLOS protein
    ORF Viral VectorpGMLP003746human DHCR7 Lentivirus plasmid
    ORF Viral VectorvGMLP003746human DHCR7 Lentivirus particle
    ORF Viral VectorpGMLPm001833mouse Dhcr7 Lentivirus plasmid
    ORF Viral VectorvGMLPm001833mouse Dhcr7 Lentivirus particle


    Target information

    Target IDGM-IP0689
    Target NameDHCR7
    Gene ID1717,13360,64191,106993167,483675,101089143,514745,100061433
    Gene Symbol and SynonymsDHCR7,SLOS
    Uniprot AccessionQ9UBM7,Q9Z2Z8,Q5E9J5
    Uniprot Entry NameDHCR7_HUMAN,DHCR7_RAT,DHCR7_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172893
    Target ClassificationN/A

    The target: DHCR7, gene name: DHCR7, also named as SLOS. This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.